Skip to content
Sunday, November 15, 2026
Dark BiotechnologyBIOTECH · GENETICS · DEVICES

Cover Story

The featured longread desk is being prepared.

Coming soon →

Genetics

Devices

A scientist arrays diagnostic cassettes beside an analyzer under glass and steel in a cool white clinical laboratory.
Devices

How In Vitro Diagnostics Are Regulated in the US and EU

In vitro diagnostics are regulated as medical devices under different instruments in the US and EU: FDA classification and premarket review in America, and the dedicated European Regulation 2017/746 in Europe.

An engineer in gloves examining a precision medical device assembly under cool white laboratory light.
Devices

How Medical Device Trials Are Designed Differently From Drug Trials

Medical device trials run on an Investigational Device Exemption, the instrument that "allows the investigational device to be used in a clinical study in order to collect safety and effectiveness data," per FDA — and all such evaluations, unless exempt, "must have an approved IDE before the study is initiated."

Tech News
A data scientist scrolling a genomic variant dashboard on dual monitors above a steel lab bench washed in cool teal light.

All of Us Release Makes the Genomics Platform the Largest Integrated Health Database

NIH's All of Us Research Program became the world's largest integrated genomic and electronic health record database with its June 30, 2026 release, which per the agency's announcement makes data from more than 747,000 participants available to scientists and includes more than 535,000 whole genome sequences linked to nearly 482,000 electronic health records.

Oliver Strnad
Tech News
A researcher adjusts a steel-jacketed bioreactor control panel, gloved hand on a dial, cool white-teal light over glass vessels, no logos.

Where Lab Automation Actually Stands in Biotech Right Now

Lab automation in biotech has moved from liquid-handling convenience to process control: a nonlinear model predictive control system developed by Sartorius researchers increased continuous CHO perfusion production by 68% while holding viable cell density at or above 95%, per a September 23, 2026 report in GEN.

Oliver Strnad